To determine the osteoblastic dysfunction that may be involved in the pathophysiology of osteoporosis in men we have compared histomorphometric indices of bone formation with in vitro characteristics of osteoblastic cells isolated from the trabecular bone surface in 23 untreated men with eugonadal osteoporosis. In most patients (n = 14), trabecular bone loss resulted from decreased bone formation evidenced by a lower than normal osteoblast surface, double tetracycline labeled surface, bone formation rate, and mean wall thickness. In these patients, DNA synthesis by cultured osteoblastic cells was altered. The peak of 1314thymidine incorporation into DNA, the maximal DNA synthesis, and the area under the curve of cell proliferation were lower than the values in normal bone cells from age-matched controls. Parameters of bone cell growth were decreased in correlation with the extent of actively bone forming surfaces. By contrast, in patients (n = 9) with normal histomorphometric indices ofbone formation, bone cell proliferation in vitro was not different from normal. Parameters of osteoblastic differentiation in vitro such as osteocalcin production and alkaline phosphatase activity were normal in the two groups of patients. This study shows that the trabecular bone loss resulting from defective bone formation in eugonadal osteoporotic men is associated with a lower than normal proliferative capacity of osteoblastic cells lining the trabecular bone surface.
Introduction
Vertebral fractures and osteoporosis are clinical entities observed in middle-aged men although their incidence is less frequent than in aged men. The etiology of the trabecular bone loss and osteopenia which results in vertebral crush fractures in young and middle-aged patients is poorly understood. An agerelated bone loss has been described in normal men (1, 2) but the trabecular bone loss occurring with age is a slow process as it results mainly from thinning of trabeculae (3, 4) rather than from perforation of trabecular plates. Several factors may be contributing to the trabecular bone loss in eugonadal men with osteoporosis. Excess ethanol intake may cause osteoporosis (5-7) by directly inhibiting osteoblast function and bone formation (8-1 1) . Tobacco use has also been reported to have deleterious effects on bone mass (5, 12, 13) and osteoblast activity (8) . Although studies on trabecular bone formation using dynamic bone histomorphometry have indicated that the recruitment and activity of osteoblasts may be altered in men with idiopathic osteoporosis (8, 11, 14) , the cellular osteoblastic dysfunction responsible for the defective bone formation in these patients remains unknown.
We have thus attempted to determine whether the reduced bone formation in eugonadal men with idiopathic osteoporosis results from an impaired proliferative capacity of osteoblastic cells or from defective bone cell differentiation. This can be determined by comparing in vivo bone forming features with in vitro osteoblastic characteristics (15, 16) . We have therefore evaluated biochemical and histomorphometric parameters of bone formation and determined in vitro characteristics ofosteoblastic cells isolated from a group ofeugonadal men with osteoporosis. We found that the defective bone formation occurring in a subgroup of men with osteoporosis is associated with an impaired proliferative capacity of osteoblastic cells in vitro.
Methods

Patients
We studied 23 untreated men (mean age: 53.9±13.4 (SD) yr; range: 21-77 yr) referred to our center for screening of osteoporosis. 16 patients had osteoporosis as defined by one or more vertebral crush fractures. Seven patients had osteopenia defined as reduced bone mineral content as evaluated by dual photon absorptiometry (< 1 SD below age-adjusted mean bone density values, which is considered to be the fracture threshold) (17) . Two patients (aged 75 and 77 yr) had involutional osteoporosis. 21 patients (mean age: 51.7±12.0 yr; range: 21-68 yr) were classified as having idiopathic eugonadal osteoporosis as none had evidence ofendocrine or neoplastic disease (18) . None had reduced serum testosterone levels, abnormal serum parathyroid hormone (fragment 1-84) levels, or low 1,25 dihydroxyvitamin D (1,25(OH)2D)' levels. 13 patients (56.5%) were mild drinkers or smokers (n = 3) or both (n = 10) as they stated that they had been drinking at least 100 g alcohol per day for several years or were smoking more than 15 packs-yr (packs/day X number ofyears smoking) or both. Among the remaining eight patients with idiopathic osteoporosis who were neither smokers nor drinkers, three had mild hypercalciuria (> 9 mmol/liter), two had a slight hypophosphatemia (< 27 mg/liter), and one had a familial history of fracture. A bone biopsy was performed in each patient after informed consent was obtained. Control histomorphometric parameters were obtained from previously studied eight normal age-matched men (mean age: 43.7±16.9 yr; range: 20-70 yr) (8) .
Serum biochemistry
Serum osteocalcin was determined in duplicate by RIA using kits obtained from ORIS (Centre d'Energie Atomique, Gifsur Yvette, France) using an antibody raised against bovine osteocalcin. The maximum inter-and intraassay coefficients of variation for the range of concentrations evaluated were 6.8% and 6.5%, respectively. The lower detection limit of the assay was 0.35 ug/liter.
Bone histomorphometry
Undecalcified transiliac bone biopsy specimens were obtained after double tetracycline labeling (labeling sequence: 2 d on, 10 d off, and 2 d on tetracycline). They were performed with an 8-mm inner diameter trephine in the antero-superior iliac crest. The biopsy was placed in sterile PBS and sectioned longitudinally to separate the biopsy in two symmetric half-cores (15, 16) . Half of the biopsy was processed for bone histomorphometry; the other halfwas used for bone cell isolation procedures. The half-core for bone morphometry was fixed in formolmethanol and embedded in methyl-methacrylate. Sections (5 gm thick) were stained with toluidine blue, and IO-,um thick sections were kept unstained for examination under fluorescent illumination. Parameters of bone formation were determined by conventional histomorphometric methods (8, 15, 16) using an integrator (Zeiss II; Carl Zeiss, Inc., Thornwood, NY) and a semiautomatic image analyzer (Leitz ASM, Rueil, France). The following parameters were measured on the endosteal surface of the trabecular bone: trabecular bone volume, expressed as a percentage ofendosteal bone tissue; osteoblast surface (percentage of trabecular bone surface covered with plump osteoblasts), and mean wall thickness (MWT; micrometers), that is the mean apparent thickness of complete bone packets, obtained by measuring the width of a complete packet perpendicular to the marrow surface (19) . The tetracycline-labeled surfaces were analyzed to determine the fractional trabecular surface covered with two labels (double labeled surface [DLS]; percentage), which represents the fraction of trabecular surface actively involved in bone formation at the time ofbiopsy, and the mineral apposition rate (micrometers per day), which represents the functional activity of osteoblasts. The total labeled surface was determined as the sum ofDLS and half ofthe single labeled surfaces. The tissue level bone formation rate (BFR) was obtained by multiplying the mineral apposition rate by total labeled surface (20) . We also determined the osteoclastic surface (percentage of trabecular bone surface covered by osteoclasts) and the number ofosteoclasts per mm2 ofbone tissue.
Bone cell cultures
Cell isolation procedure. Osteoblastic cells were isolated from the trabecular bone surfaces of half ofthe biopsy core as previously described ( 15, 16, 21) . The soft connective tissue and the periosteal and corticoendosteal bone were removed and the trabecular bone was minced in small (1-mm3) fragments. The adherent marrow cells were removed by several washes in PBS. The bone chips were then placed on an 80-Mm pore size nylon mesh maintained between two rings in culture dishes to separate adherent bone cells from smaller marrow cells (21, 22) . The bone explants were cultured in DMEM supplemented with glutamine (292 mg/liter), antibiotics (100 U/ml penicillin and 100 Mg/ml streptomycin), and 10% FCS, and were incubated at 37°C in a humidified (95%) atmosphere with 5% CO2. Cell outgrowth from the trabecular bone surfaces was apparent after 4-7 d. When confluency was obtained on the nylon mesh, the adherent cells were dissociated with 0.5 g/liter trypsin (Sigma Chemical Co., St. Louis, MO) in calcium-and magnesium-free PBS and were plated at the density required for the experimental procedures. Since we found previously that the phenotypic expression of human bone cells decreases as early as after three passages (21) , only primary cell cultures were used for analysis of DNA synthesis. For other experiments cells were used after only one cell passage. The osteoblastic cells isolated from the trabecular bone surface using this procedure consisted of > 50% alkaline phosphatase-positive, morphologically homogeneous cells which predominantly synthesize type I collagen, show alkaline phosphatase activity, and respond to human PTH (1-34) (21) . The cells also synthesize osteocalcin, a specific osteoblast protein, and its production is increased by 1,25(OH)2D (21) .
Alkaline phosphatase activity. Bone cell alkaline phosphatase activity was studied in the absence or presence of 1,25(OH)2D. Cells cultured at confluence were incubated in DMEM supplemented with 10-8 mol/liter vitamin K, 50 mg/liter ascorbic acid, and 10 g/liter BSA in the presence of 10 nmol/liter 1,25(OH)2D or solvent (ethanol). After 48 h, the cells were washed in cold PBS, the cell layer was scraped into 2 ml cold distilled water and sonicated, and the cell lysate was centrifuged. Alkaline phosphatase activity was determined in the supernatant using phenylphosphate as substrate. The protein content of the cell lysates was measured by the method ofLowry et al. (23) . The enzymatic activity was expressed as nanomoles of p-nitrophenol released per minute per milligram protein.
Osteocalcin production. Osteocalcin production was determined in the presence or absence of 10 nmol/liter 1,25(OH)2D. Cells at first passage were grown to confluence and incubated for 48 h, as described above, for the determination of alkaline phosphatase activity. After incubation, the medium was removed and the cellular protein content was determined. The medium osteocalcin concentrations were measured by RIA, as described above.
DNA synthesis. The proliferative capacity of the bone cells was measured by determining the incorporation of [3H]thymidine into DNA (15, 16, 21) . All bone cell populations from control and osteoporotic patients were plated at an identical initial density of 10,000 cells/ cm2 in 24-well plates and were cultured in DMEM supplemented with 10% FCS for 24 h to allow attachment and recovery from trypsinization. At that time (day 0), the medium was removed and replaced with DMEM with 10% FCS, and 2 MCi 6-[3H]thymidine in 50 M1 was added.
The bone cells were labeled with [3H]thymidine on days 0, 2, 6, 8, and
13, and [3H]thymidine incorporation into bone cells was determined
24 h later on days 1, 3, 7, 9, and 14 (15, 16, 21) . After 24 h the medium was removed and the cell layer was collected by trypsinization. DNA was precipitated by trichloroacetic acid and the trichloroacetic acid-insoluble fraction was dissolved in 1 mol/liter NaOH.
[3H]thymidine incorporation into DNA was measured in three to four aliquots ofthis fraction using a liquid scintillation counter. The time-course of cell proliferation was evaluated for bone cells obtained from individual patients by measuring the peak of DNA synthesis (maximal uptake of tritiated thymidine during the time-course study), the time of peak occurrence, and the area under the growth curve, measured with a digitizing table coupled to an image analyzer (Leitz ASM). The overall proliferation of bone cell population was further estimated by determining the cumulative [3H]thymidine uptake into DNA up to day 14 of culture (cumulative peak) (15, 16 Bone histomorphometric data. The histomorphometric analysis showed that bone formation parameters were variable in the whole group. The patients were thus separated into two groups according to DLS which represents the extent of actively bone forming surfaces. 14 osteoporotic men had DLS values lower than the mean value-2 SD in age-matched normal men (normal value 5.4±1.1 [SD]) and were defined as having low bone formation. The other nine patients were considered to have a normal extent ofbone forming surfaces as they had DLS values within the normal range (Fig. 1) . Table I shows that the mean trabecular bone volume in patients with low or normal DLS was lower than the values in normal age-matched men. Patients with low DLS had a lower than normal MWT, reduced osteoblast surface, decreased total labeled surface, and low BFR. The osteoblast surface, total labeled surface, double labeled surface, and BFR were lower in patients with decreased DLS than in the normal DLS group (Table I, Fig. 1) . However, the mineral apposition rate was normal in the two groups ofpatients. DLS was found to correlate strongly with the osteoblast surface (r = 0.80, P < 0.001).
Parameters ofbone resorption were not different from normal in patients with low DLS. By contrast, the number of osteoclasts/mm2 of bone tissue was higher than normal in patients with normal DLS (Table I) .
Clinical and biochemical data. The incidence of vertebral fractures in patients with low DLS was identical to that in the patients with normal DLS (1.9±1. (Table II) . 1,25(OH)2D (10 nmol/liter, 48 h) had variable effects on alkaline phosphatase activity and the change was of similar amplitude in bone cells from osteoporotic men with low or normal DLS and in normal subjects.
Basal osteocalcin production by osteoblastic cells was not significantly different from normal in the two groups of patients. The response to 1,25(OH)2D was also similar as osteocalcin synthesis was increased to comparable levels in bone 10- value in patients with normal DLS is indicated by one asterisk (P < 0.05) and two asterisks (P < 0.01), respectively. cells from osteoporotic patients and in normal subjects. Basal and osteocalcin production corrected for cell protein were also not significantly different in the two groups and the magnitude ofresponse to 1,25(OH)2D was similar in patients with low and normal DLS and in normal subjects (Table II) .
DLS activity in men -------------------------------------.with idiopathic osteopo-
DNA synthesis. The proliferative characteristics of osteoblastic cells evaluated by [3H]thymidine incorporation into DNA indicate that bone cells from osteoporotic men with low DLS had a reduced rate of cell proliferation compared to normal bone cells. The time-course analysis of [3H]thymidine incorporation showed that DNA synthesis was lower than normal at day 9-14 ofculture in bone cells from osteoporotic men with low DLS (Fig. 2) . In these subjects, the mean peak ofDNA synthesis (maximal [3H]-thymidine uptake during the timecourse study) was 54% lower than normal (Table III) . The mean cumulative peak of [3H]thymidine uptake at day 14 of culture was 23.5% lower than normal and the average area under the curve of cell proliferation was 30% lower than in normal bone cells (Table III) . By contrast, the time-course study showed that DNA synthesis was identical to normal values in bone cells from osteoporotic patients with normal DLS (Fig. 2) . The osteoblastic cells from these patients had a normal rate of cell proliferation in vitro as also shown by the normal proliferative characteristics of these cells (Table III) .
In vitro parameters ofcell proliferation were found to correlate with histomorphometric indices of bone formation. The area under the proliferative curve correlated linearly with the total labeled surface and with DLS (Fig. 3) . Also, the osteoblastic surface (r = 0.39; P < 0.05), DLS (r = 0.46; P < 0.05), and the cumulative peak of DNA synthesis (r = 0.34; P < 0.05) were found to decrease with the age of the patients.
Discussion
With the aim of establishing the cellular dysfunction responsible for the trabecular bone loss in men with eugonadal osteoporosis we have compared the histomorphometric indices ofbone formation and the in vitro characteristics of osteoblastic cells isolated from the same trabecular bone. The activity of bone formation was evaluated by DLS as this dynamic parameter estimates the extent of actively bone forming surfaces (15, 18) . DLS correlated with the extent ofmorphologically active osteoblasts which further indicates that this index represents the active osteoblastic population. As previously reported (18) a histologic heterogeneity was apparent in osteoporotic men. Some patients were found to have normal parameters ofbone formation with increased bone resorption compared to age-matched nonosteoporotic men. Histomorphometric results in these patients showed a trend for a high osteoclast surface and significantly increased osteoclast number, suggesting that the reduced trabecular bone volume resulted from a higher rate of bone resorption relative to bone formation. In other patients including the two patients with involutional osteoporosis, the indices of bone formation were lower than normal with normal bone resorption parameters, suggesting that osteopenia resulted from defective bone formation. We found no difference in circulating osteocalcin levels in osteoporotic men with low and normal DLS, probably because of the limited number of patients in our study.
Patients with decreased DLS also had low osteoblast surface, reduced BFR, and lower than normal MWT. The mineral Values are the mean ±SD. * Significant difference compared to age-matched controls (P < 0.05). $Significant difference (P < 0.05) compared to the mean value in patients with decreased DLS.
apposition rate was, however, normal, indicating that the decreased trabecular bone volume in these patients resulted from a reduced osteoblastic population rather than alteration of the activity of individual osteoblasts. A defective bone formation due to decreased osteoblastic number or activity has been found in osteoporotic men who were mostly alcoholic and heavy smokers (8) and in nonalcoholic men with osteoporosis (14) . Our report indicates that the decreased bone formation in men with idiopathic osteoporosis resulted from a lower than normal osteoblastic population rather than altered osteoblastic activity.
To establish whether the decreased bone formation in osteoporotic men with low DLS resulted from defective osteoblastic recruitment or function we have studied the parameters of bone cell proliferation and differentiation in vitro. Alkaline phosphatase activity and osteocalcin synthesis are parameters which characterize the osteoblastic phenotype (24). No significant difference was found in the basal osteocalcin production and alkaline phosphatase activity between the two groups of osteoporotic patients. The osteocalcin production in vitro in response to 1 ,25(OH)2D at optimal dosage and time of culture for human bone cells derived from the trabecular surface (21) was also not different in patients with low or normal DLS. In addition, basal values for osteocalcin and the amplitude of response to 1,25(OH)2D in osteoblastic cells from osteoporotic men were not different from the values in cells isolated from cohol may however affect other cell types since ethanol has been reported to increase bone resorption in vitro (10) and in vivo (26) . Tobacco consumption is a risk factor for osteoporosis (5, 27) and 52% of our patients were mild smokers. Smoking has a detrimental effect on trabecular bone density (28) and bone formation (8) . Although tobacco or alcohol use may be involved in the osteoblast dysfunction in osteoporotic men, these factors may not be of major importance in all patients since 27% of the drinkers/smokers had normal bone formation. Other contributing factors such as low body weight (27, 29) , decreased physical activity (30) , and genetic components (18) may also be important. Aging could also be one factor involved in osteoblast dysfunction as the two patients with involutional osteoporosis had decreased bone formation and subnormal bone cell growth in vitro. We also observed an inverse relationship between the extent ofbone forming sites and DNA synthesis and age in our patients. Although parameters of bone formation have been reported to decrease with age in normal subjects (31) this point remains controversial. Further studies are required to establish whether there is a decrease in osteoblastic cell proliferation with age.
In conclusion, we found that the trabecular bone loss and decreased bone formation in most eugonadal men with idiopathic osteoporosis was associated with a lower than normal osteoblastic cell proliferation in vitro whereas parameters of bone cell differentiation were not affected. This study indicates that the defective bone formation and reduced osteoblast population in a subgroup of osteoporotic men results from an impaired proliferative capacity of osteoblastic cells lining the trabecular bone surface.
